A complete loss of a gene, as described in the MGI database, as well as pathogenic mutations, which in the case of CDKN2A can lead to hereditary cancer in human (36), are expected to display much stronger effects than regulatory influences such as those exerted by hsa-miR-4513. Here, CDKN2A is linked to hereditary cancer.